The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

(U.S.) $2.07

Today's change-0.11 -5.05%
Updated July 24 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

(U.S.) $2.07

Today's change-0.11 -5.05%
Updated July 24 4:00 PM -4GMT. Delayed by at least 15 minutes.

Galectin Therapeutics Inc down (U.S.)$0.11

Galectin Therapeutics Inc closed sharply lower Monday, dropping (U.S.)$0.11 or 5.05% to (U.S.)$2.07. Shares have lost 13.75% over the last five days, but have gained 111.27% over the last year to date. This security has outperformed the S&P 500 by 24.44% during the last year.

Key company metrics

  • Open(U.S.) $2.18
  • Previous close(U.S.) $2.18
  • High(U.S.) $2.24
  • Low(U.S.) $2.05
  • Bid / Ask(U.S.) $2.01 / (U.S.) $0.00
  • YTD % change+111.27%
  • Volume183,433
  • Average volume (10-day)111,715
  • Average volume (1-month)116,157
  • Average volume (3-month)357,164
  • 52-week range(U.S.) $0.49 to (U.S.) $3.68
  • Beta2.55
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.68
Updated July 24 4:00 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

    No News Results.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue------0
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense5556
Selling / general / administrative1111
Research & development4334
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5-5-5-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-5-5-6
Income after tax-5-5-5-6
Income tax, total--------
Net income-5-5-5-6
Total adjustments to net income01-10
Net income before extra. items-5-5-5-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-4-6-6
Inc. avail. to common incl. extra. items-5-4-6-6
Diluted net income-5-4-6-6
Dilution adjustment--------
Diluted weighted average shares34302929
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.13-0.19-0.20
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.15-0.13-0.19-0.20